Delivery Order SPE2DB20D1004-SPE2DB22FF9X9

Award Date 8/1/22
Potential Completion Date 8/2/22
Potential Value $5.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRAJ2, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count quantities, with a ceiling value of $1,422.08. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
This federal contract award, valued at $1,052.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,826,397 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The award has an ultimate completion date of April 8, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pantoprazole Sodium Delayed-Release 40 mg tablets. The $1,049.48 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,169.21, is for the delivery of Pantoprazole Sodium Delayed-Release Tablets, 40 mg, in 1,000-count quantities. This is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,247.30, is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count containers. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,432.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pantoprazole Sodium Delayed-Release Tablets, 40 mg, in 1,000-count bottles. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FQE54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,132.94, is for the delivery of 4,564,451,658 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets 1000s. This is a Firm Fixed Price delivery order contract with a completion date of May 1, 2024. The contract does not have a set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets. The contract has a ceiling value of $1,680.79 and is a Firm Fixed Price Delivery Order, with a period of performance through June 3, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,146.52 Firm Fixed Price Delivery Order contract is for the supply of 4,567,364,223 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has a period of performance through February 25, 2025 and was awarded on February 24, 2025. This award is part of a larger $999,999,999 Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,872.98, is for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in 1,000-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB22FF9X9
    Delivery Order

This federal contract award, identified as SPE2DB20D1004|SPE2DB22FF9X9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,337.78, is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in quantities of 1,000.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:27 AM